Person: . Digital therapeutics: The key to maximizing the potential of medicinal assets, Harder to find homes: Latest wave of biotech layoffs could test the industry, Roche, Exelixis' Tecentriq/Cabometyx combo flunks second PhIII, A radioactive prostate cancer therapy is a last lifeline for patients. And thats not including the Teva deal. [1], In October 2003, Saunders was hired as senior vice president of global compliance and business practices at pharmaceutical company Schering-Plough. At the time, federal prosecutors had started investigating expenses at teaching hospitals, a probe that would expand in the years ahead. In terms of consolidation, Saunders said theres pressure on the health care industry to contain costs and boost production, and he expects the integrations to continue moving forward. Saunders as the companys third CEO in four years was put in charge of a 157-year-old company that hadnt grown in decades. And then theres Healther Bresch, CEO of Mylan, who would collect an $87.8 million payout. There were plenty of people who stood up at a podium on their first day and said, I have the plan to change this company, only to not be there a year later, Saunders said. When .css-gegin5{-webkit-text-decoration:underline;text-decoration:underline;text-decoration-thickness:0.0625rem;text-decoration-color:inherit;text-underline-offset:0.25rem;color:#9a0500;-webkit-transition:all 0.3s ease-in-out;transition:all 0.3s ease-in-out;}.css-gegin5:hover{color:#595959;text-decoration-color:border-link-body-hover;}Beto O'Rourke officially entered the presidential race on March 14, he released a video of himself and his wife, Amy O'Rourke, comfortably seated on a couch in their El Paso home. He has also brought along a former colleague to Vesper: Manisha Narasimhan, who was senior vice president of strategic initiatives, portfolio innovation and investor relations at Allergan having previously worked at Regeneron and as an analyst at Canaccord and Piper Jaffray. Then I wash my face with Sanoflore Aqua Magnifica (opens in new tab)you put a little bit on a cotton round and then you clean your skin, it's all floral, super natural. Saunders, who spent eight weeks in Israel during a summer break in high school, also did a summer semester in Tokyo as part of a study abroad program with Pitt and Seikei University. Another reason to take comfort. [1], In mid-2007, he became president of consumer health care at Schering-Plough, with responsibility for a business unit of products including Coppertone, Dr. Scholl's and Claritin. Few people would have thought that Saunders would be in the top position when he was named CEO of Forest Labs less than three eventful years ago. Prior to the $63 billion takeover by AbbVie, Allergans biggest product was botulinum toxin product Botox, best known as a wrinkle and migraine treatment, and that headed a sizeable medical aesthetics portfolio at the company which also included dermal filler products like Juvederm. They would try pretty much anything, and they were resilient enough that if it didnt work out, they had four other ideas., Brent and Wayne also held some traditional jobs growing up, such as delivering The Morning Call and working at Dorney Park & Wildwater Kingdom. I love music. Saunders had rejected previous approaches by Teva, but this time around, the price was high enough. According to Country, Baier planned to . Other childhood ventures included a backyard volleyball court, where they charged $5 a head, a record store that never quite came to fruition and a six-member rock band called Axtion, with Brent on rhythm guitar and Wayne on the synthesizer. Long before Saunders cemented his reputation as one of the biggest dealmakers in the pharmaceutical industry, he was a 13-year-old business owner cutting lawns in the South Whitehall Township neighborhood where he grew up. I'm always in bed at 9:30, except if we have a dinner or something like that. Just since its name change, the company has announced several acquisitions: depression-treatment developer Naurex for $560 million, glaucoma treatment company AqueSys for $300 million, dry-eye disease treatment-maker Oculeve for $125 million and Kythera Biopharmaceuticals for $2.1 billion. But the decision actually predated the lawsuit, according to a spokesperson, who told Endpoints News that Gannex decided at the end of 2021 not to pursue a US Phase II trial of ASC41. She is the morning editor at Marie Claire, and her work has appeared in the likes of InStyle, Cosmopolitan, Bustle and Shape. Amy was not pleased by what she learned about campaigning. With their earnings, the brothers saved for college, funded ski trips and even bought a Trans Am. Charles and his wife, Sheila, who co-founded Senior Solutions, the Lehigh Valleys first geriatric-care management agency, raised their three children Brent, Wayne and daughter Reed on Cedarwood Road in South Whitehall. Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. Saunders graduated from Parkland High School in 1988. [2] In December, Saunders made his first deal with Vesper when he acquired HydraFacial, a beauty treatment company, for $1.1 billion. The company expects revenues of about $15 billion this year. He created the "Allergan Social Contract with Patients", with the stated aim of prohibiting price gouging and offering better patient access to Allergan medicines. Brenton L. Saunders, president and CEO of Allergan, in his office in Parsippany, New Jersey. I started doing acupuncture and my life changed. If you're already an Endpoints subscriber, enter your email below for a If I'm for example in Colombia, in Cartagena, or I'm here and I'm working out, I maybe listen to more reggaeton or something more energetic. Charles River inks gene therapy development and manufacturing pact with South Korean biopharma. These days, Amy is the "choose to excel director" at CREEED, a nonprofit focused on helping students in El Paso County public schools. His father was a company man at General Electric, and his mother worked for Merck and Schering . If he had 10 more minutes in the day, Saunders said, he would spend it with front-line colleagues. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. Saunders is on the board of directors of Cisco Systems and RWJBarnabas Health, and is a member of the Business Council and PhRMA. And in preparation for her husband's presidential run, she picked up Michelle Obama's Becoming. Events + Child Mind Institute Child Advocacy Award Dinner. Then I use Better Than Sex (opens in new tab) mascara. Brent Saunders, president and CEO of Allergan, poses for a photo in the garage of his childhood home where growing up, he and his brother Wayne had a bike repair shop. He is the former chairman of the New York chapter of the American Heart Association. Beto and Amy kiss onstage during election night in 2018. Brenton L. Saunders was born on 6 February, 1970 in Arizona, United States, is a Businessman. Delaware-incorporated Vesper has filed a with a $400 million initial public offering (IPO) and plans to list on the Nasdaq under the symbol VSRU, with Goldman Sachs and JP Morgan acting as bookrunners. Brent L. Saunders, president and CEO of Allergan, is seen in his office in Parsippany, New Jersey. John Carroll Editor & Founder. The sale of its generic drug business gives Allergan an opportunity to simplify its business and invest in its seven therapeutic areas, including eye care, aesthetics and womens health. Thanks to constant advances in technology and science, artificial intelligence (AI) is rapidly becoming an integral part of modern healthcare. During the IPO roadshow in late May, Saunders had just fallen asleep in his New York hotel on the Wednesday before Memorial Day weekend when he got a late-night call from J. Michael Pearson, CEO of Canada-based Valeant Pharmaceuticals. It also faced investigations into a kickback it paid to a health insurer and the marketing of its drugs for unapproved uses, according to the U.S. Department of Justice. Baier was born in Rumson, New Jersey, to a family of mixed German and Irish origins. I use a serumEven Up from Colorescience (opens in new tab), then I use [the brands] SPF. Before joining Actavis in July 2014, which was later renamed Allergan, he was president and CEO of Forest Laboratories. * Education: Graduated from Parkland High School in 1988. By March 2013, when Bausch & Lomb filed for an initial public offering, the company under Saunders leadership had introduced 30 new products since 2010, had 35 products at various stages of development in its pipeline and grew sales at an annualized 9 percent for the two years ended December 2012, according to documents filed with the U.S. Securities and Exchange Commission. When you purchase through links on our site, we may earn an affiliate commission. Brenton L. Saunders, president and CEO of Allergan, in his office in Parsippany, New Jersey. Chloe is a News Writer for Townandcountrymag.com, where she covers royal news, from the latest additions to Meghan Markles staff to Queen Elizabeths monochrome fashions; she also writes about culture, often dissecting TV shows like The Marvelous Mrs Maisel and Killing Eve. So when Merck & Co. bought Schering-Plough in 2009 for $41 billion, Schering-Plough chose Saunders to lead its integration team. O'Rourke will appear in tonight's Democratic Party debates. Amy Saunders. Owner: saunders, brenton l & amy b. Analysts agree Saunders is a well-spoken and humble leader who is very responsive and strategic in what hes building at Allergan. [15] In September, Saunders special-purpose acquisition company Vesper Healthcare Acquisition publicly launched, raising $400 million. Ever wonder how they get it all done in a day? I do acupuncture, like once a week, especially on my back when I'm stressed or I have anxiety. Hassan, hired as CEO of Kenilworth, N.J., pharmaceutical company Schering-Plough in April 2003, was tasked with turning around a company that saw its stock drop more than 50 percent in the prior two years. The Portland, Oregon native attended Northwestern University's Medill School of Journalism before joining the Chicago American. But as he continued to work with Saunders, plans changed. In September 2013, he was named CEO of Forest Laboratories Inc., where hed been a director since August 2011. The update came just weeks after the drug involved, an oral small molecule candidate and THR agonist named ASC41, became the subject of a lawsuit in which Viking Therapeutics accused Ascletis of stealing trade secrets. While at Bausch & Lomb, he led the company to a sales growth of 9% a year and oversaw the introduction of 34 new products before its acquisition by Valeant Pharmaceuticals in 2013 for $8.7 billion. A February cover of Forbes dubbed Saunders Wall Streets Drug Dealer, painting him as a leader who prioritizes shareholder value over inventing new drugs. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. At Allergan, headquartered in Dublin, Ireland, for tax reasons but operating in Parsippany, N.J., Saunders is transforming the company into a leader in what he calls growth pharma. In the second quarter, sales increased for 12 of the companys top 15 global brands, which include anti-wrinkle treatment Botox, chronic dry eye drug Restasis and high blood pressure tablet Bystolic. Baier, 50, is also the chief political correspondent for Fox. Ex-Allergan CEO Brent Saunders pops up again in blank cheque company Vesper Healthcare, looking to buy "medical aesthetics, eyecare, longevity and wellness" assets Summit, NJ. I love the way they dress. How Brent Saunders' Allergan experiment failed. Saunders took over as CEO of Allergan in 2014 after the generics company Actavis, which he was heading at the time, took over both the Botox maker and its name. Adding Tecentriq, Roches blockbuster PD-L1 antibody, to Exelixis Cabometyx did not meet the primary endpoint of progression-free survival for a group of patients with kidney cancer who have already received checkpoint therapy, Exelixis wrote in a terse update on the CONTACT-03 study. At only 45 years old, Saunders already has billions of dollars worth of mergers and acquisitions under his belt, with the most recent being Allergan's $40 billion sale of its generics business to Teva.
